Talking with Family Planning Clients About COVID-19 Vaccination

November 18, 2021

This webinar event is a collaboration between The California Department of Health Care Services Office of Family Planning, the California Prevention Training Center, the California Department of Public Health, and “#ThisIsOurShot” Program.

Please join two OBGYNs, Dr. LaTanya Hines and Dr. Michael Policar, for a webinar training on how to effectively communicate with your clients about COVID-19 vaccination, including overall safety, safety and efficacy during pregnancy and post-partum lactation, and the evidence regarding COVID-19 vaccination and future fertility.

Learning Objectives:

  • Why it’s important for clinicians and family planning counselors to discuss COVID-19 vaccination with clients who are seen for family planning services
  • Key messages that address common concerns of reproductive-aged individuals about the COVID-19 vaccine, especially among people who are considering becoming pregnant, are currently pregnant, and those who are lactating
  • An evidence-based methodology to tackle tough vaccine conversations and get to “yes”

Presenters:

Resources:

2021 Implementing the CDC STI Treatment Guidelines: A Conversation for Family PACT Providers

The long-awaited 2021 CDC Sexually Transmitted Infections Treatment Guidelines were published in MMWR on July 22, 2021. This webinar will focus on significant changes from the 2015 CDC STD Treatment Guidelines, including updated guidelines for the screening, diagnosis and treatment of gonorrhea, chlamydia, syphilis, pelvic inflammatory disease, genital herpes, Mycoplasma genitalium, and vaginal trichomoniasis. To assist health care providers in obtaining a sexual history, the updated “Five P’s” approach will be reviewed. In addition, current Family PACT benefits for each type of sexually transmitted infection discussed in the program will be explained.

Learning Objectives:

  • List 3 examples of sexual history questions for each the “Five P’s” of sexual history taking
  • Explain why the treatment guidelines for both chlamydia and gonorrhea genital tract infections were updated in the 2021 Guidelines
  • List the indications for obtaining chlamydia and gonorrhea samples from the anus and the oropharynx
  • Describe the consequences of Mycoplasma genitalium genital infection in males and females
  • List 2 updates in the 2021 Guidelines regarding vaginal trichomoniasis

Presenters:

Resources:

STD Expert Hour Webinar – New Frontiers in STI/HIV Prevention and Family Planning: The promise of Multipurpose Prevention Technologies

Wednesday, June 23, 2021

Presented by Bethany Young Holt, PhD, MPH

Learn about the latest developments in the field of Multipurpose Prevention Technologies (MPTs), products that provide contraception along with protection from STIs and/or HIV.

The origins of MPTs and the current research/development pipeline will also be discussed.

Learning Objectives:

  1. Provide evidence of the need for products that simultaneously address multiple health risks, such as HIV, other STIs, and unplanned pregnancy
  2. Introduce and implement Multipurpose Prevention Technologies (MPTs) and the product candidates currently in development for prevention of HIV, other STIs and/or unintended pregnancies
  3. Describe the Initiative for MPTs (IMPT) and its publicly-available tools for tracking the MPT product development pipeline, while summarizing the current pipeline profile, recent scientific breakthroughs, and the potential impact of MPTs for women around the world
  4. Outline next steps for key stakeholders in STI prevention and related health fields, with a focus on tangible priority actions that will help bring MPTs to the hands of end-users

The CPT rules for the use of problem-oriented E/M office visit codes changed significantly on January 1, 2021. Since then, office visits are coded based on levels of medical decision-making or “total time” and the prior rules for using the “three key components” no longer apply. Consequently, Family PACT E/M coding policies were updated in February 2021, as well as the publication of a new policy on coding and billing for counselor services.

Learning Objectives:

  1. List at least six activities that can be counted in the “total time” of a visit when computing E/M level
  2. List each of the 3 elements used in medical decision-making, and give examples of each
  3. Describe the Family PACT policy for coding for a clinician visit and counselor services on the same date of service

Presenter:

  • Michael Policar, MD, MPH

Resources:

Vaccinating Pregnant Individuals

Vaccinating Pregnant Individuals

Guidance and procedures from the American College of Obstetricians and Gynecologists (ACOG) about the COVID-19 vaccine for pregnant and lactating individuals.

ACOG logo

Birth Control Methods

Birth Control Methods

Information on birth control methods and Family PACT coverage for current and prospective Family PACT clients.

FamilyPACT logo

Clinical Practice Alert: Emergency Contraception

Clinical Practice Alert: Emergency Contraception

An overview of and frequently asked questions about emergency contraception (EC). EC represents a “last chance” to prevent unintended pregnancy. Categories of EC are emergency contraceptive pills (ECPs), including ulipristal acetate (UPA) and levonorgestrel (LNG) and the copper intrauterine device (IUD).

Holding an IUD birth control device in hand

Holding an IUD birth control copper coil device in hand, used for contraception –

Clinical Practice Alert: Chlamydia and Gonorrhea Screening and Treatment

Clinical Practice Alert: Chlamydia and Gonorrhea Screening and Treatment

Key recommendations for chlamydia and gonorrhea screening and treatment for individuals assigned female at birth.

FamilyPACT logo

Clinical Practice Alert: Cervical Cancer Screening

Clinical Practice Alert: Cervical Cancer Screening

Key recommendations for cervical cancer screening from the American College of Obstetricians and Gynecologists (ACOG) and the multidisciplinary partnership of the American Cancer Society, the American Society for Colposcopy and Cervical Pathology (ASCCP), and the American Society for Clinical Pathology.